Allergy Therapeutics News and Activities

Allergy Therapeutics is a company listed under the stock ticker AGY (GB).

Allergy Therapeutics has a direct presence in 2 countries.

View the org chart displaying its 30 main executives

Most searched biographies at Allergy Therapeutics

• Manuel Llobet, Chief Executive Officer and Director
• Tunde Otulana, Non-Executive Director
• David Ball, Independent Non-Executive Director

Popular executive movements at Allergy Therapeutics

• Helge Weiner has joined the company as Chief Strategy Officer and Executive Director  (posted on January 7 2026).
• Lawrence Allen Wang has joined the company as Non-Executive Director  (posted on January 7 2026).

Create your alert
to follow the executive moves at Allergy Therapeutics.

Allergy Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Allergy Therapeutics

Social media about Allergy Therapeutics

• Allergy Therapeutics on Wikipedia, Google News & Yahoo Finance
• Allergy Therapeutics on LinkedIn, X (Twitter) & YouTube